ID   CCKAR_RAT               Reviewed;         444 AA.
AC   P30551;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   24-JUL-2024, entry version 157.
DE   RecName: Full=Cholecystokinin receptor type A;
DE            Short=CCK-A receptor;
DE            Short=CCK-AR;
DE   AltName: Full=Cholecystokinin-1 receptor;
DE            Short=CCK1-R;
GN   Name=Cckar;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 111-158; 270-314 AND
RP   392-402.
RC   TISSUE=Pancreas;
RX   PubMed=1313582; DOI=10.1073/pnas.89.7.3125;
RA   Wank S.A., Harkins R., Jensen R.T., Shapira H., de Weerth A., Slattery T.;
RT   "Purification, molecular cloning, and functional expression of the
RT   cholecystokinin receptor from rat pancreas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:3125-3129(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=7654260; DOI=10.1006/bbrc.1995.2222;
RA   Takata Y., Takiguchi S., Funakoshi A., Kono A.;
RT   "Gene structure of rat cholecystokinin type-A receptor.";
RL   Biochem. Biophys. Res. Commun. 213:958-966(1995).
RN   [3]
RP   DISULFIDE BONDS.
RX   PubMed=12916469; DOI=10.3109/10606820308249;
RA   Ding X.Q., Dolu V., Hadac E.M., Schuetz M., Miller L.J.;
RT   "Disulfide bond structure and accessibility of cysteines in the ectodomain
RT   of the cholecystokinin receptor: specific mono-reactive receptor constructs
RT   examine charge-sensitivity of loop regions.";
RL   Recept. Channels 9:83-91(2003).
RN   [4]
RP   ANTAGONIST BINDING.
RX   PubMed=8024583; DOI=10.1006/bbrc.1994.1856;
RA   Mantamadiotis T., Baldwin G.S.;
RT   "The seventh transmembrane domain of gastrin/CCK receptors contributes to
RT   non-peptide antagonist binding.";
RL   Biochem. Biophys. Res. Commun. 201:1382-1389(1994).
CC   -!- FUNCTION: Receptor for cholecystokinin. Mediates pancreatic growth and
CC       enzyme secretion, smooth muscle contraction of the gall bladder and
CC       stomach. Has a 1000-fold higher affinity for CCK rather than for
CC       gastrin. It modulates feeding and dopamine-induced behavior in the
CC       central and peripheral nervous system. This receptor mediates its
CC       action by association with G proteins that activate a
CC       phosphatidylinositol-calcium second messenger system.
CC       {ECO:0000269|PubMed:7654260}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Pancreas and brain. Also expressed in the
CC       gastrointestinal system and vagus nerve. {ECO:0000269|PubMed:7654260}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M88096; AAA40899.1; -; mRNA.
DR   EMBL; D50608; BAA09170.1; -; Genomic_DNA.
DR   PIR; A42685; A42685.
DR   RefSeq; NP_036820.1; NM_012688.3.
DR   AlphaFoldDB; P30551; -.
DR   SMR; P30551; -.
DR   STRING; 10116.ENSRNOP00000063137; -.
DR   BindingDB; P30551; -.
DR   ChEMBL; CHEMBL2871; -.
DR   DrugCentral; P30551; -.
DR   GuidetoPHARMACOLOGY; 76; -.
DR   GlyCosmos; P30551; 3 sites, No reported glycans.
DR   GlyGen; P30551; 3 sites.
DR   iPTMnet; P30551; -.
DR   PhosphoSitePlus; P30551; -.
DR   PaxDb; 10116-ENSRNOP00000063137; -.
DR   Ensembl; ENSRNOT00060026909; ENSRNOP00060021578; ENSRNOG00060015710.
DR   GeneID; 24889; -.
DR   KEGG; rno:24889; -.
DR   AGR; RGD:2289; -.
DR   CTD; 886; -.
DR   RGD; 2289; Cckar.
DR   eggNOG; KOG3656; Eukaryota.
DR   InParanoid; P30551; -.
DR   OrthoDB; 3686620at2759; -.
DR   PhylomeDB; P30551; -.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   PRO; PR:P30551; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005768; C:endosome; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0004951; F:cholecystokinin receptor activity; IDA:RGD.
DR   GO; GO:0042277; F:peptide binding; IBA:GO_Central.
DR   GO; GO:0017046; F:peptide hormone binding; ISO:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IEP:RGD.
DR   GO; GO:0038188; P:cholecystokinin signaling pathway; ISO:RGD.
DR   GO; GO:0042755; P:eating behavior; IMP:RGD.
DR   GO; GO:0007631; P:feeding behavior; IDA:RGD.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0001696; P:gastric acid secretion; IDA:RGD.
DR   GO; GO:0030073; P:insulin secretion; IDA:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0031016; P:pancreas development; IEP:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0090274; P:positive regulation of somatostatin secretion; IMP:RGD.
DR   GO; GO:0002023; P:reduction of food intake in response to dietary excess; IMP:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IDA:RGD.
DR   GO; GO:0046883; P:regulation of hormone secretion; IBA:GO_Central.
DR   GO; GO:0043266; P:regulation of potassium ion transport; IDA:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0042594; P:response to starvation; IMP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0001659; P:temperature homeostasis; IMP:RGD.
DR   Gene3D; 4.10.670.10; Cholecystokinin A receptor, N-terminal domain; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR009126; Cholcskin_rcpt.
DR   InterPro; IPR000596; Cholcy_rcpt_A.
DR   InterPro; IPR015276; CholecystokininA_recpt_N.
DR   InterPro; IPR036472; CholecystokininA_recpt_N_sf.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24238:SF77; CHOLECYSTOKININ RECEPTOR TYPE A; 1.
DR   PANTHER; PTHR24238; G-PROTEIN COUPLED RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   Pfam; PF09193; CholecysA-Rec_N; 1.
DR   PRINTS; PR01822; CCYSTOKININR.
DR   PRINTS; PR00524; CCYSTOKNINAR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Direct protein sequencing; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane; Palmitate;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..444
FT                   /note="Cholecystokinin receptor type A"
FT                   /id="PRO_0000069226"
FT   TOPO_DOM        1..56
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        57..82
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        83..92
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        93..119
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        120..130
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        131..152
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        153..172
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        173..193
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        194..225
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        226..249
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        250..329
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        330..350
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        351..365
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        366..389
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        390..444
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          263..288
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           403
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        25
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        39
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        205
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        33..44
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:12916469"
FT   DISULFID        129..211
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   444 AA;  49657 MW;  B435BE7505C2FB11 CRC64;
     MSHSPARQHL VESSRMDVVD SLLMNGSNIT PPCELGLENE TLFCLDQPQP SKEWQSALQI
     LLYSIIFLLS VLGNTLVITV LIRNKRMRTV TNIFLLSLAV SDLMLCLFCM PFNLIPNLLK
     DFIFGSAVCK TTTYFMGTSV SVSTFNLVAI SLERYGAICR PLQSRVWQTK SHALKVIAAT
     WCLSFTIMTP YPIYSNLVPF TKNNNQTANM CRFLLPSDAM QQSWQTFLLL ILFLLPGIVM
     VVAYGLISLE LYQGIKFDAS QKKSAKEKKP STGSSTRYED SDGCYLQKSR PPRKLELQQL
     SSGSGGSRLN RIRSSSSAAN LIAKKRVIRM LIVIVVLFFL CWMPIFSANA WRAYDTVSAE
     KHLSGTPISF ILLLSYTSSC VNPIIYCFMN KRFRLGFMAT FPCCPNPGPP GVRGEVGEEE
     DGRTIRALLS RYSYSHMSTS APPP
//
